TP53 Mut AML with a CK has been described as a genotype with extremely poor outcomes [18,19,20], suggesting that this group of patients should be assigned to a distinct “very-adverse-risk" category group [11,17]. The gene discussed is TP53; the disease is acute myeloid leukemia.